Responding to public feedback, CMS has decided against finalizing the proposed Local Coverage Determination (LCD) for MolDx ...
This LCD focuses on skin substitutes for the treatment of diabetic foot ulcers (DFU) and venous leg ulcers (VLU) in the Medicare population. CMS developed the LCD mechanism to create a policy ...
The agency made multiple decisions regarding coverage for diagnostic and laboratory testing that have affected the industry.
the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD) 1 policy regarding skin substitute grafts/cellular and tissue-based products for the ...